CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Agreement ended · Auditor change
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 10-K/A Report 10-K/A
- 8-K Event Restatement
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K/A Event Delisting notice
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
Page 7 of 9 · 166 filings